Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Obstet Gynecol. 2018 Oct;132(4):875–881. doi: 10.1097/AOG.0000000000002854

Table 3:

Neonatal Outcomes According to the Institute of Medicine Gestational Weight Gain Categories

Outcome Gestational Weight Gain
Below
N=6,338
Within (referent)
N=8,296
Above
N=15,227
N (%) Unadjusted OR (95%CI)
p-value
Adjusted OR (95%CI)
p-value
N (%) N (%) Unadjusted OR (95%CI)
p-value
Adjusted OR (95%CI)
p-value
Preterm birth* 751 (11.9%) 1.59 (1.42–1.77)
p<0.001
1.47 (1.31–1.64)
p<0.001
648 (7.8%) 1324 (8.7%) 1.12 (1.02–1.24)
p=0.02
1.05 (0.95–1.16)
p=0.32
Spontaneous preterm birth* 471 (7.4%) 1.59 (1.39–1.82)
p<0.001
1.50 (1.31–1.73)
p<0.001
399 (4.8%) 712 (4.7%) 0.97 (0.86–1.10)
p=0.64
0.93 (0.82–1.06)
p=0.27
Indicated preterm birth* 280 (4.4%) 1.49 (1.26–1.78)
p<0.001
1.34 (1.12–1.60)
p=0.002
249 (3.0%) 612 (4.0%) 1.35 (1.17–1.57)
p<0.001
1.24 (1.07–1.45)
p=0.006
Shoulder dystocia
in vaginal delivery only *
85 (1.9%) 0.87 (0.66– 1.15)
p=0.34
0.86 (0.65–1.13)
p=0.28
126 (2.1%) 357 (3.6%) 1.71 (1.39–2.10)
p<0.001
1.74 (1.41–2.14)
p<0.001
Macrosomia * ‡‡ 35 (0.55%) 0.68 (0.45–1.03)
p=0.07
-- 67 (0.81%) 317 (2.08%) 2.61 (2.00–3.40)
p<0.001
2.66 (2.03–3.48)
p<0.001
Treatment for neonatal hypoglycemia * ‡‡ 45 (0.71%) 1.16 (0.77–1.73)
p=0.48
-- 51 (0.61%) 149 (0.98%) 1.60 (1.16–2.20)
p=0.004
1.60 (1.16–2.22)
p=0.005
*

The analysis was adjusted for maternal age, race-ethnicity, tobacco use, parity, insurance type, chronic hypertension, pre-gestational diabetes, and hospital type.

The denominator for the shoulder dystocia outcome varies from the total sample size because it was limited to women with vaginal deliveries (N=4,587 below; N=5,948 within; N=10,002 above).

‡‡

Due to the low frequency of macrosomia and neonatal hypoglycemia and gestational weight gain below the guidelines, the adjusted ORs were not reported.

The bolded values indicate statistical significance.

OR odds ratio

CI Confidence interval